Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 159

1.

Association Between Serum Vitamin D Levels and Parkinson's Disease: A Systematic Review and Meta-Analysis.

Luo X, Ou R, Dutta R, Tian Y, Xiong H, Shang H.

Front Neurol. 2018 Nov 12;9:909. doi: 10.3389/fneur.2018.00909. eCollection 2018.

2.

Treatment of Levodopainduced dyskinesia with Vitamin D: A Randomized, double-blind, placebo-controlled trial.

Habibi AH, Anamoradi A, Shahidi GA, Razmeh S, Alizadeh E, Kokhedan KM.

Neurol Int. 2018 Oct 1;10(3):7737. doi: 10.4081/ni.2018.7737. eCollection 2018 Sep 5.

3.

Serum 25-hydroxyvitamin D3 level may be associated with olfactory dysfunction in de novo Parkinson's disease.

Kim JE, Oh E, Park J, Youn J, Kim JS, Jang W.

J Clin Neurosci. 2018 Nov;57:131-135. doi: 10.1016/j.jocn.2018.08.003. Epub 2018 Aug 19.

PMID:
30135017
4.

Brain region-dependent gene networks associated with selective breeding for increased voluntary wheel-running behavior.

Zhang P, Rhodes JS, Garland T Jr, Perez SD, Southey BR, Rodriguez-Zas SL.

PLoS One. 2018 Aug 2;13(8):e0201773. doi: 10.1371/journal.pone.0201773. eCollection 2018.

5.

Parkinson's disease with hypocalcaemia: adult presentation of 22q11.2 deletion syndrome.

Moreira F, Brás A, Lopes JR, Januário C.

BMJ Case Rep. 2018 Mar 22;2018. pii: bcr-2017-223751. doi: 10.1136/bcr-2017-223751.

PMID:
29572372
6.

Effect of Vitamin D in HN9.10e Embryonic Hippocampal Cells and in Hippocampus from MPTP-Induced Parkinson's Disease Mouse Model.

Cataldi S, Arcuri C, Hunot S, Mecca C, Codini M, Laurenti ME, Ferri I, Loreti E, Garcia-Gil M, Traina G, Conte C, Ambesi-Impiombato FS, Beccari T, Curcio F, Albi E.

Front Cell Neurosci. 2018 Feb 7;12:31. doi: 10.3389/fncel.2018.00031. eCollection 2018.

7.

Vitamin D and Breast Cancer: Latest Evidence and Future Steps.

Atoum M, Alzoughool F.

Breast Cancer (Auckl). 2017 Dec 20;11:1178223417749816. doi: 10.1177/1178223417749816. eCollection 2017. Review.

8.

Neutral Sphingomyelinase Behaviour in Hippocampus Neuroinflammation of MPTP-Induced Mouse Model of Parkinson's Disease and in Embryonic Hippocampal Cells.

Cataldi S, Arcuri C, Hunot S, Légeron FP, Mecca C, Garcia-Gil M, Lazzarini A, Codini M, Beccari T, Tasegian A, Fioretti B, Traina G, Ambesi-Impiombato FS, Curcio F, Albi E.

Mediators Inflamm. 2017;2017:2470950. doi: 10.1155/2017/2470950. Epub 2017 Nov 16.

9.

The Role of Vitamin D in Disease Progression in Early Parkinson's Disease.

Sleeman I, Aspray T, Lawson R, Coleman S, Duncan G, Khoo TK, Schoenmakers I, Rochester L, Burn D, Yarnall A.

J Parkinsons Dis. 2017;7(4):669-675. doi: 10.3233/JPD-171122.

10.

Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study.

Fullard ME, Xie SX, Marek K, Stern M, Jennings D, Siderowf A, Willis AW, Chen-Plotkin AS.

Mov Disord. 2017 Nov;32(11):1636-1640. doi: 10.1002/mds.27127. Epub 2017 Sep 14.

11.

Serum Klotho, vitamin D, and homocysteine in combination predict the outcomes of Chinese patients with multiple system atrophy.

Guo Y, Zhuang XD, Xian WB, Wu LL, Huang ZN, Hu X, Zhang XS, Chen L, Liao XX.

CNS Neurosci Ther. 2017 Aug;23(8):657-666. doi: 10.1111/cns.12711. Epub 2017 Jun 19.

PMID:
28628270
12.

Peripheral neuropathy in 30 duodopa patients with vitamins B supplementation.

Rispoli V, Simioni V, Capone JG, Golfrè Andreasi N, Preda F, Sette E, Tugnoli V, Sensi M.

Acta Neurol Scand. 2017 Dec;136(6):660-667. doi: 10.1111/ane.12783. Epub 2017 Jun 12.

PMID:
28608472
13.

No clear support for a role for vitamin D in Parkinson's disease: A Mendelian randomization study.

Larsson SC, Singleton AB, Nalls MA, Richards JB; International Parkinson's Disease Genomics Consortium (IPDGC).

Mov Disord. 2017 Aug;32(8):1249-1252. doi: 10.1002/mds.27069. Epub 2017 Jun 8.

14.

Vitamin D receptor gene polymorphisms, smoking, and risk of sporadic Parkinson's disease in Japan.

Tanaka K, Miyake Y, Fukushima W, Kiyohara C, Sasaki S, Tsuboi Y, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M, Nakamura Y; Fukuoka Kinki Parkinson’s Disease Study Group.

Neurosci Lett. 2017 Mar 16;643:97-102. doi: 10.1016/j.neulet.2017.02.037. Epub 2017 Feb 16.

PMID:
28216333
15.

Calcipotriol inhibits α-synuclein aggregation in SH-SY5Y neuroblastoma cells by a Calbindin-D28k-dependent mechanism.

Rcom-H'cheo-Gauthier AN, Meedeniya AC, Pountney DL.

J Neurochem. 2017 Apr;141(2):263-274. doi: 10.1111/jnc.13971.

16.

Association of UV radiation with Parkinson disease incidence: A nationwide French ecologic study.

Kravietz A, Kab S, Wald L, Dugravot A, Singh-Manoux A, Moisan F, Elbaz A.

Environ Res. 2017 Apr;154:50-56. doi: 10.1016/j.envres.2016.12.008. Epub 2016 Dec 26.

PMID:
28033496
17.

Roles of PPAR transcription factors in the energetic metabolic switch occurring during adult neurogenesis.

Di Giacomo E, Benedetti E, Cristiano L, Antonosante A, d'Angelo M, Fidoamore A, Barone D, Moreno S, Ippoliti R, Cerù MP, Giordano A, Cimini A.

Cell Cycle. 2017 Jan 2;16(1):59-72. doi: 10.1080/15384101.2016.1252881. Epub 2016 Nov 18.

18.

Vitamin D receptor gene polymorphisms and cognitive decline in Parkinson's disease.

Gatto NM, Paul KC, Sinsheimer JS, Bronstein JM, Bordelon Y, Rausch R, Ritz B.

J Neurol Sci. 2016 Nov 15;370:100-106. doi: 10.1016/j.jns.2016.09.013. Epub 2016 Sep 11.

19.

Vitamin D3 regulates LAMP3 expression in monocyte derived dendritic cells.

Malaguarnera L, Marsullo A, Zorena K, Musumeci G, Di Rosa M.

Cell Immunol. 2017 Jan;311:13-21. doi: 10.1016/j.cellimm.2016.09.013. Epub 2016 Sep 28.

PMID:
27697285
20.

Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.

Binks S, Dobson R.

Curr Osteoporos Rep. 2016 Oct;14(5):199-210. doi: 10.1007/s11914-016-0320-5. Review.

PMID:
27525980

Supplemental Content

Loading ...
Support Center